These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19336864)

  • 1. Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study.
    Kaur G; Carnelio S; Rao N; Rao L
    Indian J Dent Res; 2009; 20(1):71-6. PubMed ID: 19336864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between E-cadherin expression, clinical stage and tumour differentiation in oral squamous cell carcinoma.
    Yamada K; Jordan R; Mori M; Speight PM
    Oral Dis; 1997 Jun; 3(2):82-5. PubMed ID: 9467347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases.
    Balasundaram P; Singh MK; Dinda AK; Thakar A; Yadav R
    Diagn Pathol; 2014 Jul; 9():145. PubMed ID: 25047112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
    Zaid KW
    Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin, β-catenin, and α2β1 and α3β1 integrin expression in primary oral squamous cell carcinoma and its regional metastasis.
    Soares MQ; Mendonça JA; Morais MO; Leles CR; Batista AC; Mendonça EF
    Histol Histopathol; 2015 Oct; 30(10):1213-22. PubMed ID: 25857731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma.
    Hung KF; Chang CS; Liu CJ; Lui MT; Cheng CY; Kao SY
    J Oral Pathol Med; 2006 Nov; 35(10):589-94. PubMed ID: 17032390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis.
    Mahomed F; Altini M; Meer S
    Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
    Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
    Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Correlative Study of N-Cadherin Expression with Different Grades of Oral Squamous Cell Carcinoma Projecting as a Marker of Epithelial to Mesenchymal Transition in Tumor Progression.
    Rai K H; Ahmed J
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2327-2332. PubMed ID: 31450902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma.
    Wang YF; Chen JY; Chang SY; Chiu JH; Li WY; Chu PY; Tai SK; Wang LS
    Int J Cancer; 2008 Jan; 122(2):377-86. PubMed ID: 17918157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
    Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J
    Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
    Chandolia B; Rajliwal JP; Bajpai M; Arora M
    J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
    Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
    Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenilin 1/γ-secretase modulates P-cadherin processing and influences cell adhesion in oral squamous cell carcinoma cell lines.
    Bauer K; Gosau M; Reinders J; Oefner P; Reichert TE; Bauer R
    Carcinogenesis; 2013 Nov; 34(11):2622-8. PubMed ID: 23740836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
    Zhou J; Tao D; Xu Q; Gao Z; Tang D
    Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changed expression of E-cadherin and galectin-9 in oral squamous cell carcinomas but lack of potential as prognostic markers.
    Chan SW; Kallarakkal TG; Abraham MT
    Asian Pac J Cancer Prev; 2014; 15(5):2145-52. PubMed ID: 24716948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of E-cadherin in Progression of Oral Squamous Cell Carcinoma: A Retrospective Immunohistochemical Study.
    Gupta A; Sharma S; Batra M; Abidullah M; Bhuvinder S; Katragadda P
    J Contemp Dent Pract; 2018 Sep; 19(9):1105-1110. PubMed ID: 30287712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma.
    Jiang Y; Liao L; Shrestha C; Ji S; Chen Y; Peng J; Wang L; Liao E; Xie Z
    Int J Clin Exp Pathol; 2015; 8(8):9042-51. PubMed ID: 26464646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.